Obeticholic acid, a synthetic FXR agonist, prevents hepatic inflammation and fibrosis in a novel mouse model of non-alcoholic steatohepatitis

被引：0
|
作者：
Goto, Toshihiro [1 ,2 ]
Itoh, Michiko [2 ]
Kanai, Sayaka [2 ]
Suganami, Takayoshi [3 ,4 ]
Ogawa, Yoshihiro [2 ,5 ]
机构：
[1] Sumitomo Dainippon Pharma Co Ltd, Drug Dev Res Labs, Osaka, Japan
[2] Tokyo Med & Dent Univ, Tokyo, Japan
[3] Nagoya Univ, Nagoya, Aichi 4648601, Japan
[4] JST PRESTO, Tokyo, Japan
[5] AMED CREST, Tokyo, Japan
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1609
引用
收藏
页码：797A / 798A
页数：2
相关论文
共 50 条
  • [41] The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis
    Griffett, Kristine
    Welch, Ryan D.
    Flaveny, Colin A.
    Kolar, Grant R.
    Neuschwander-Tetri, Brent A.
    Burris, Thomas P.
    MOLECULAR METABOLISM, 2015, 4 (04): : 353 - 357
  • [42] Chemerin in a Mouse Model of Non-alcoholic Steatohepatitis and Hepatocarcinogenesis
    Haberl, Elisabeth M.
    Pohl, Rebekka
    Rein-Fischboeck, Lisa
    Feder, Susanne
    Sinal, Christopher J.
    Buechler, Christa
    ANTICANCER RESEARCH, 2018, 38 (05) : 2649 - 2657
  • [43] Nifedipine prevents hepatic fibrosis in a non-alcoholic steatohepatitis model induced by an L-methionine-and choline-deficient diet
    Nakagami, Hironori
    Shimamura, Munehisa
    Miyake, Takashi
    Shimosato, Takashi
    Minobe, Noriko
    Moritani, Toshinori
    Osako, Mariana Kiomy
    Nakagami, Futoshi
    Koriyama, Hiroshi
    Kyutoku, Mariko
    Shimizu, Hideo
    Katsuya, Tomohiro
    Morishita, Ryuichi
    MOLECULAR MEDICINE REPORTS, 2012, 5 (01) : 37 - 40
  • [44] Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model
    Aoyama, Yoshinaga
    Naiki-Ito, Aya
    Xiaochen, Kuang
    Komura, Masayuki
    Kato, Hiroyuki
    Nagayasu, Yuko
    Inaguma, Shingo
    Tsuda, Hiroyuki
    Tomita, Mamoru
    Matsuo, Yoichi
    Takiguchi, Shuji
    Takahashi, Satoru
    NUTRIENTS, 2022, 14 (01)
  • [45] MODULATION OF HEPATIC FIBROSIS AND LIPID CONTENT BY CASPASE IN NON-ALCOHOLIC STEATOHEPATITIS
    Hatting, M.
    Cubero, F. J.
    Zhao, G.
    Schumacher, F.
    Sellge, G.
    Liedtke, C.
    Gassler, N.
    Trautwein, C.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S491 - S491
  • [46] Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
    Zhang, Songwen
    Wang, Juan
    Liu, Qiangyuan
    Harnish, Douglas C.
    JOURNAL OF HEPATOLOGY, 2009, 51 (02) : 380 - 388
  • [47] Filamin A is overexpressed in non-alcoholic steatohepatitis and contributes to the progression of inflammation and fibrosis
    Lu, Ying
    Wang, Mengzhu
    Zhao, Manyu
    Zhang, Qianru
    Qian, Rui
    Hu, Zan
    Ke, Qi
    Yu, Lin
    Wang, Liqun
    Lai, Qinhuai
    Liu, Zhenmi
    Jiang, Xia
    Zhang, Ben
    Yang, Jinliang
    Yao, Yuqin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 653 : 93 - 101
  • [48] The L-carnitine alleviate hepatic fibrosis in a non-alcoholic steatohepatitis
    Sunagozaka, Hajime
    Honda, Masao
    Yamashita, Taro
    Okada, Hikari
    Oishi, Naoki
    Shimakami, Tetsuro
    Kitamura, Kazuya
    Arai, Kuniaki
    Sakai, Yoshio
    Yamashita, Tatsuya
    Nagata, Naoto
    Takamura, Toshinari
    Mizukoshi, Eishiro
    Kaneko, Shuichi
    HEPATOLOGY, 2015, 62 : 872A - 872A
  • [49] Effects of a PEGylated fibroblast growth factor 21 variant on steatosis, inflammation, and fibrosis in a mouse model of non-alcoholic steatohepatitis
    Zinker, B.
    Boehm, S.
    Gao, S.
    He, A.
    Strassle, B.
    Morin, P.
    Christian, R.
    Krupinski, J.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S390 - S390
  • [50] Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis
    Hameed, B.
    Terrault, N. A.
    Gill, R. M.
    Loomba, R.
    Chalasani, N.
    Hoofnagle, J. H.
    Van Natta, M. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (05) : 645 - 656
12345